A-75943
A-75943 is a bone resorption inhibitor isolated from Streptomyces sp. SANK 61296, with protein synthesis toxicity. A-75943 inhibits bone resorption in vitro, and also suppresses the increase in serum calcium levels and the decrease in bone mineral density in thyroparathyroidectomized rats. A-75943 inhibits protein synthesis. High concentrations of A-75943 reduce the survival rate of osteoclasts on bone slices, while low concentrations have no effect on the survival rate or morphology of osteoclasts. A-75943 can be used for the research of osteoporosis and hypercalcemia.
商品は「研究用試薬」です。人や動物の医療用・臨床診断用・食品用の製品ではありません。
研究用途以外に使用した場合、当社は一切の責任を負いかねます。
- CAS 番号: 201215-10-3
- 分子式: C15H23NO4
- 分子量:281.35
-
保管条件:
Please store the product under the recommended conditions in the Certificate of Analysis.
生物活性
製品説明
体外実験
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
体内実験
A-75943 (3-30 mg/kg; s.c.; daily; day 4 to day 10 post-thyroparathyroidectomy) dose-dependently suppresses Ro13-6298 (HY-106735)-induced increases in serum Ca2+ and decreases in bone mineral density in thyroparathyroidectomized rats, with the 30 mg/kg dose producing the strongest effects[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:Wistar Imamichi (male, 8-week-old, thyroparathyroidectomized)[1]
-
Dosage:3 mg/kg; 30 mg/kg
-
Administration:s.c.; daily; day 4 to day 10 post-thyroparathyroidectomy
-
Result:Suppressed Ro-136298-induced increases in serum Ca2+ and decreases in bone mineral density in a dose-dependent manner.
Achieved serum Ca2+ concentrations of 6.99 mg/dl on day 0, 10.66 mg/dl on day 5, and 12.51 mg/dl on day 7 at 3 mg/kg.
Reached bone mineral density of 129.9 mg/cm2 at 3 mg/kg.
Achieved serum Ca2+ concentrations of 6.92 mg/dl on day 0, 8.14 mg/dl on day 5, and 9.29 mg/dl on day 7 at 30 mg/kg.
Reached bone mineral density of 134.4 mg/cm2 at 30 mg/kg.
-
Animal Model:Wistar Imamichi (male, 8-week-old, thyroparathyroidectomized)[1]
-
Dosage:10 mg/kg
-
Administration:s.c.; daily; day 4 to day 10 post-thyroparathyroidectomy
-
Result:Suppressed Ro-136298-induced increases in serum Ca2+ and decreases in bone mineral density.
Achieved serum Ca2+ concentrations of 5.71 mg/dl on day 0, 8.85 mg/dl on day 5, and 12.04 mg/dl on day 7.
Reached bone mineral density of 128.3 mg/cm2.
化学情報
-
CAS 番号 201215-10-3
-
分子量 281.35
-
分子式 C15H23NO4
-
SMILES
O=C1[C@]([C@]2(C[C@@H](CC(N)=O)CC(=O)O2)[H])(C[C@@H](C)C[C@@H]1C)[H]
-
輸送条件
Room temperature in continental US; may vary elsewhere.
-
保管条件
Please store the product under the recommended conditions in the Certificate of Analysis.
純度とドキュメンテーション
参考文献
Calculators
濃度 (開始) × 体積 (開始) = 濃度 (終了) × 体積 (終了)
Keywords
- A-75943
- 201215-10-3
- A75943
- A 75943
- Antibiotic
- Endogenous Metabolite
- Streptomyces sp. SANK 61296
- protein synthesis
- osteoporosis
- hypercalcemic diseases
- thyroid and parathyroid-extracted rats
- osteoclast
- bone mineral density
- thyroparathyroidectomized rats
- bone resorption
- mouse unfractionated bone cell cultures
- Inhibitor
- inhibitor
- inhibit